X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare FDC LTD. with Abbott India - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs ABBOTT INDIA - Comparison Results

ABBOTT INDIA 
   Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FDC LTD. ABBOTT INDIA FDC LTD./
ABBOTT INDIA
 
P/E (TTM) x 29.1 44.5 65.4% View Chart
P/BV x 6.1 11.1 54.5% View Chart
Dividend Yield % 0.8 0.6 129.2%  

Financials

 FDC LTD.   ABBOTT INDIA
EQUITY SHARE DATA
    FDC LTD.
Mar-14
ABBOTT INDIA
Mar-16
FDC LTD./
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs1446,015 2.4%   
Low Rs793,707 2.1%   
Sales per share (Unadj.) Rs47.61,236.9 3.8%  
Earnings per share (Unadj.) Rs7.6122.2 6.2%  
Cash flow per share (Unadj.) Rs9.0129.0 7.0%  
Dividends per share (Unadj.) Rs2.2535.00 6.4%  
Dividend yield (eoy) %2.00.7 280.9%  
Book value per share (Unadj.) Rs47.5521.2 9.1%  
Shares outstanding (eoy) m177.8321.25 836.8%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x2.33.9 59.5%   
Avg P/E ratio x14.639.8 36.7%  
P/CF ratio (eoy) x12.337.7 32.8%  
Price / Book Value ratio x2.39.3 25.1%  
Dividend payout %29.628.6 103.2%   
Avg Mkt Cap Rs m19,784103,296 19.2%   
No. of employees `000NA3.0 0.0%   
Total wages/salary Rs m1,2213,370 36.2%   
Avg. sales/employee Rs ThNM8,891.8-  
Avg. wages/employee Rs ThNM1,140.0-  
Avg. net profit/employee Rs ThNM878.3-  
INCOME DATA
Net Sales Rs m8,45926,284 32.2%  
Other income Rs m394504 78.0%   
Total revenues Rs m8,85226,789 33.0%   
Gross profit Rs m2,0703,665 56.5%  
Depreciation Rs m249144 172.5%   
Interest Rs m318 382.8%   
Profit before tax Rs m2,1844,017 54.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m-2250-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6061,421 42.6%   
Profit after tax Rs m1,3532,596 52.1%  
Gross profit margin %24.513.9 175.5%  
Effective tax rate %27.735.4 78.4%   
Net profit margin %16.09.9 162.0%  
BALANCE SHEET DATA
Current assets Rs m4,35514,446 30.1%   
Current liabilities Rs m1,7924,725 37.9%   
Net working cap to sales %30.337.0 81.9%  
Current ratio x2.43.1 79.5%  
Inventory Days Days4451 86.5%  
Debtors Days Days2520 126.1%  
Net fixed assets Rs m3,0251,113 271.8%   
Share capital Rs m179213 84.0%   
"Free" reserves Rs m8,24310,808 76.3%   
Net worth Rs m8,45311,076 76.3%   
Long term debt Rs m110-   
Total assets Rs m10,55716,241 65.0%  
Interest coverage x71.4497.0 14.4%   
Debt to equity ratio x00-  
Sales to assets ratio x0.81.6 49.5%   
Return on assets %13.116.0 81.8%  
Return on equity %16.023.4 68.3%  
Return on capital %23.536.3 64.7%  
Exports to sales %13.30.6 2,164.6%   
Imports to sales %3.312.6 26.4%   
Exports (fob) Rs m1,126162 696.6%   
Imports (cif) Rs m2833,322 8.5%   
Fx inflow Rs m1,146268 427.6%   
Fx outflow Rs m3553,927 9.0%   
Net fx Rs m791-3,659 -21.6%   
CASH FLOW
From Operations Rs m1,4852,514 59.1%  
From Investments Rs m-620-800 77.5%  
From Financial Activity Rs m-753-803 93.7%  
Net Cashflow Rs m113912 12.4%  

Share Holding

Indian Promoters % 68.9 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 4.7 7.9 59.5%  
FIIs % 7.5 0.1 7,500.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.0 17.1 111.1%  
Shareholders   23,730 18,270 129.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FDC LTD. With:   DR. REDDYS LAB  STERLING BIOTECH  JUBILANT LIFE SCIENCES  AUROBINDO PHARMA  IPCA LABS  

Compare FDC LTD. With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Global Stock Markets Chart Modest Gains(RoundUp)

Global financial markets ended the holiday shortened week with modest gains. The rally put behind days of decline as concerns regarding swift interest rates hikes were put to ease.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

The Foundation for Sensex 100,000 is Laid(The 5 Minute Wrapup)

Feb 17, 2018

Top three reasons for Tanushree's presentation at Equitymaster Conference to be centered around a possible 30% correction.

India's Rs 1,66,276 Crore Problem(Vivek Kaul's Diary)

Feb 15, 2018

That's the loss, the government owned public sector enterprises are expected to make this year.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

How I Beat the Index by 2x... And Why I Believe This Could Happen Again(Smart Contrarian)

Feb 12, 2018

Will Microcap Millionaires be able to replicate its past performance of beating the index by 2x?

NPAs Set to Rise Further with New RBI Rules(Chart Of The Day)

Feb 15, 2018

The RBI overhauls bad loan framework. Banks may come under additional pressure due to rising NPAs and increased provisioning.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Feb 23, 2018 (Close)

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FDC LTD. 8-QTR ANALYSIS

COMPARE FDC LTD. WITH

MARKET STATS